Feb 21, 2026 06:00AM
Jan 7, 2026 04:05PM
Dec 17, 2025 04:05PM
Dec 17, 2025 04:05PM
Dec 15, 2025 04:07PM
Nov 3, 2025 04:05PM
Nov 3, 2025 04:05PM Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely
Oct 6, 2025 04:55AM
Oct 6, 2025 04:00AM
Oct 5, 2025 11:00AM
Sep 29, 2025 04:05PM
Sep 29, 2025 04:05PM
Sep 23, 2025 04:05PM
Sep 23, 2025 04:05PM Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
Jul 23, 2025 04:17PM
Jul 23, 2025 04:15PM
Jul 23, 2025 07:54AM
Jul 22, 2025 04:05PM
Jul 22, 2025 04:05PM
Apr 29, 2025 04:05PM
Apr 22, 2025 04:05PM Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Apr 22, 2025 04:00PM
Apr 22, 2025 04:00PM
Jan 28, 2025 02:30AM
Jan 9, 2025 11:35AM
Jan 2, 2025 12:51PM
Dec 23, 2024 04:07PM
Dec 23, 2024 04:05PM Abivax Announces a Change to the Composition of its Board of Directors
Nov 19, 2024 04:31PM
Nov 19, 2024 04:30PM
Nov 14, 2024 04:01PM
Nov 13, 2024 04:03PM
Nov 13, 2024 04:01PM
Oct 7, 2024 04:01PM
Oct 3, 2024 04:01PM Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
Oct 3, 2024 06:00AM
Oct 3, 2024 02:31AM
Sep 26, 2024 02:30AM
Sep 25, 2024 04:01PM
Sep 25, 2024 04:01PM
Aug 6, 2024 02:30AM
Jul 15, 2024 04:00PM Abivax (ABVX) Provides Operational and Key Program Update
Jul 15, 2024 04:00PM
Jun 4, 2024 04:10PM
Feb 13, 2024 02:50AM
Sep 19, 2019 02:03PM
Jul 11, 2019 04:34PM
May 13, 2019 02:00AM
Mar 14, 2019 02:00AM Abivax 2018 Financial Results and Operations Update
Nov 9, 2018 02:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All